Alzheimers
-
Amyloid-Beta Plaques: How Alzheimer’s Forms and Blood Tests
NEW YORK, July 16 — For the millions of families touched by Alzheimer’s disease, the science can feel impossibly distant. But behind…
-
Alzheimer’s Amyloid Hypothesis Receives Strongest Clinical Validation Yet
ISLAMABAD, July 14 — A decades-old theory about what drives Alzheimer’s disease has received its strongest clinical validation to date, as new…
-
FDA’s critical decision looms on full approval for Alzheimer’s drug
WASHINGTON, July 14 — The U.S. Food and Drug Administration granted accelerated approval to lecanemab, marketed as Leqembi, on January 6, 2023,…
-
New Alzheimer’s Drug Lecanemab Slows Cognitive Decline in Trial
WASHINGTON, July 14 — For the millions of American families watching a loved one slowly lose their memories, the arrival of lecanemab…
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992
LONDON, July 10 — John Hardy, the British geneticist and neuroscientist who first proposed that amyloid-beta accumulation is the primary cause of…
-
Alzheimer’s Drug Lecanemab Slows Cognitive Decline 27% in Trial
MANILA, July 10 — For millions of families across Asia and around the world, the shadow of Alzheimer’s disease has long been…
-
Alzheimer’s 2024: Prevalence, Costs, and Clinical Trial Data
WASHINGTON, July 8 — The numbers arrive with the cold weight of an epidemic that refuses to recede. By 2024, an estimated…
-
Lecanemab and Donanemab: Biology of Amyloid-Targeting Drugs
ISLAMABAD, July 8 — For decades, the sticky clumps of protein that build up in the brains of Alzheimer’s patients have been…
-
Alzheimer’s Research Breakthroughs Target Disease Progression in 2024
WASHINGTON — For the millions of American families touched by Alzheimer’s disease, the past few years have brought something that once felt…
-
Tire chemical linked to new Alzheimer’s risk factor
SAN FRANCISCO — A study published in 2024 in the journal Environmental Health Perspectives has identified a chemical, 6PPD-quinone, as a potential…
-
UCSF’s Dr. John Morris Leads Alzheimer’s-Tire Chemical Study
SAN FRANCISCO — The detail that matters in Alzheimer’s research is increasingly found not in the petri dish but in the environment…
-
Key Players in the Research: UCSF and Collaborators Behind the Study
SAN FRANCISCO, July 7 — A chemical compound found in virtually every car tyre on the road has been linked to biological…
-
Mechanism of Action: How 6PPD-Q May Disrupt Brain Cell Function
MANILA, July 7 — A new study has identified a mechanism through which a common environmental pollutant may contribute to Alzheimer’s disease,…
-
6PPD-Q Link Sparks Urgent Regulatory and Research Action
SAN FRANCISCO — A tire chemical already flagged by the Environmental Protection Agency for killing salmon may now be linked to Alzheimer’s…
-
Alzheimer’s Disease: A Progressive Neurodegenerative Disorder
WASHINGTON, July 7 — On the seventh floor of a downtown research institute, a neurologist pulls up a brain scan on a…
-
Alzheimer’s Cases in U.S. to Reach 13.8 Million by 2060
WASHINGTON, July 7 — The figure that matters: 6.7 million. That is the number of Americans aged 65 and older living with…
-
Alzheimer’s Disease: A Growing Public Health Crisis in the US
LONDON, July 7 — The technical reality of Alzheimer’s disease remains stubbornly grim, even as researchers chip away at its mechanisms. It…
-
Tire pollution compound linked to Alzheimer’s-like brain changes
CHICAGO, July 7 — On the ground in laboratories across the country, researchers are tracking a new suspect in the long fight…
-
Omega-3 health update after major new study into claims
LOS ANGELES, June 30 — 365 older adults. Two years. Zero measurable brain benefit from fish oil supplements. That is the bottom…
-
High-Dose Fish Oil Shows No Cognitive Benefit in Older Adults at Alzheimer’s Risk
LOS ANGELES — For two years, researchers tracked 365 older adults who took high doses of fish oil. The result, published by…
-
Sunlight could be crucial to preventing dementia, study finds
LONDON, June 27 — Getting enough sunlight could be crucial in preventing dementia, a study has found. People who spend, on average,…
-
Blood Protein GDF15 at Age 45 Linked to Dementia Risk 30 Years Later
MANILA — A single protein floating in the bloodstream could tell doctors whether a 45-year-old will develop dementia three decades later. That…
-
New Study Reveals Long, Silent Buildup of Brain Changes Before Dementia Onset
The clock on dementia starts ticking long before the first forgotten name. New research confirms what many in the longevity field have…
-
Diet may lower dementia risk even after early brain changes
NEW YORK, June 25 — The figure that matters: brain changes that can eventually lead to dementia may begin many years before…
Most read
-
Minnesota Makes Personal Finance Course Mandatory for High School Graduation
-
UK Households With £10,000 Risk Losing £300 To Low Interest Rates
-
Selangor International Care Expo in Kuala Lumpur 2026
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Why Long COVID Raises Hypertension Risk and How to Monitor Your Blood Pressure
-
Amgen and AstraZeneca Combination Therapy Shows Unprecedented Survival Gains in Lung Cancer
-
Moderna’s mRNA Platform Enables Rapid Personalized Cancer Vaccines
-
Evaluating Skyrizi’s Efficacy and Market Position in Crohn’s Disease Care
-
How Personalized mRNA Vaccines Target Neoantigens to Beat Melanoma
-
Nationwide Rate Boost: How Rising Cash ISA Yields Beat Inflation Without Long-Term Lock-Ins
-
Estate Taxes Hit Retirees Selling High-Value Art: Navigating Double Taxation Risks
-
How Revolving Credit Card Balances Drive Industry Profits and Stifle Budgets
-
Why Medicare Documentation Rules Drive Denied Claims for Diabetic Shoes
-
Suze Orman: Why Medical Costs Demand an 8-Month Emergency Fund
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Dennis Lo Pioneers Liquid Biopsy for Cancer and Prenatal Testing
-
New Research Highlights Rising Internet Addiction Debate
-
Study Suggests Drinking Water With Meals May Lead To Overeating
-
Real-World Oncotype DX Adoption: Rates and Key Challenges
-
Energy Drinks: Youth Marketing, Caffeine Risks Under Scrutiny
-
ADHD Dopamine Dysfunction Disrupts Sleep-Wake Cycles, Study Finds